School of Medicine


Showing 1-10 of 11 Results

  • James L. Zehnder, M.D.

    James L. Zehnder, M.D.

    Professor of Pathology (Research) and of Medicine (Hematology)

    Current Research and Scholarly InterestsOur laboratory focuses on translational research in 2 main areas - genomic approaches to diagnosis and minimal residual disease testing for patients with cancer, and molecular basis of disorders of thrombosis and hemostasis. My clinical focus is in molecular pathology, diagnosis and treatment of disorders of hemostasis and thrombosis and general hematology.

  • Jamie Zeitzer

    Jamie Zeitzer

    Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
    He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders.

  • Bing Melody Zhang

    Bing Melody Zhang

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsMy main research interests lie in the following areas:
    1) Using genetic/genomic approaches to study the genotype-phenotype correlation of inherited non-malignant hematologic disorders, especially platelet disorders.
    2) Development and application of molecular assays for clinical testing to support hematopoietic stem cell transplantation and solid organ transplantation.
    3) NGS-based TCR/Ig clonality/MRD diagnostic testing.
    4) HLA-related disease association and pharmacogenetic testing.

  • Chongyang Zhang

    Chongyang Zhang

    Postdoctoral Scholar, Cardiology

    BioDr. Zhang is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. She has a PhD in Pharmacology from University of Rochester, NY. She has research in cardiovascular research and chronobiology published in high impact peer-reviewed journals. She is recipient of honors including predoctoral fellowship from AHA, Travel Grant for Early Career Investigators from Council on Arteriosclerosis, Thrombosis, and Vascular Biology. She has served as ad hoc reviewer for more than 40 manuscripts for reputed journals.

  • Quan Zhou

    Quan Zhou

    Instructor, Neurosurgery

    Current Research and Scholarly InterestsDr. Zhou has made substantial contributions to the field of biomedical engineering. Dr. Zhou conducts her research on a highly specialized area focusing on molecular imaging, which has applications in biomedical imaging and clinical oncology. Dr. Zhou’s research addresses some of the nation’s most pressing issues related to the development of effective biomedical imaging approaches for accurate diagnosis of prevalent human diseases and improving effectiveness of their treatment. Her innovations in biomedical imaging technology are important for detection and management of deadly diseases including brain, head-and-neck, pancreatic, liver and colorectal cancers as well as cardiovascular sclerosis. Her strong background in biological sciences and biomedical engineering as well as her experience in both translational and clinical research have helped her develop multiple disease-specific molecular probes and miniature imaging devices for image-guided surgery of cancers and cardiovascular plaque detection.

    Dr. Zhou’s research has led to emergence of novel solutions and opportunities, in particular, for molecular imaging of cancer and other diseases, for discovering, leveraging and integration of cancer biomarker and tumor microenvironment information, and for novel approaches to acquire real-time high-resolution contrast enhanced cancer visualization and optimization based on imaging depth, quality and speed. Dr. Zhou has been able to formulate the involved clinical and biological problems into biomedical engineering frameworks and find ways to exploit a variety of modern techniques and approaches from photoacoustic imaging, fluorescence-guided surgery, micro-electromechanical systems and biomedical instrumentation in developing elegant and effective solutions. Her work in the Neurosurgery Department and Molecular Imaging Program at Stanford involves research related to developing tumor-specific molecular probes, advanced imaging methods and therapeutic delivery systems for adult and pediatric patients with malignant brain cancers to improve margin detection, enhance resection accuracy, and improve treatment outcome.

  • J. Bradley Zuchero

    J. Bradley Zuchero

    Assistant Professor of Neurosurgery

    Current Research and Scholarly InterestsGlia are a frontier of neuroscience, and overwhelming evidence from the last decade shows that they are essential regulators of all aspects of the nervous system. The Zuchero Lab aims to uncover how glial cells regulate neural development and how their dysfunction contributes to diseases like multiple sclerosis (MS) and in injuries like stroke.

    Although glia represent more than half of the cells in the human brain, fundamental questions remain to be answered. How do glia develop their highly specialized morphologies and interact with neurons to powerfully control form and function of the nervous system? How is this disrupted in neurodegenerative diseases and after injury? By bringing cutting-edge cell biology techniques to the study of glia, we aim to uncover how glia help sculpt and regulate the nervous system and test their potential as novel, untapped therapeutic targets for disease and injury.

    We are particularly interested in myelin, the insulating sheath around neuronal axons that is lost in diseases like MS. How do oligodendrocytes- the glial cell that produces myelin in the central nervous system- form and remodel myelin, and why do they fail to regenerate myelin in disease? Our current projects aim to use cell biology and neuroscience approaches to answer these fundamental questions. Ultimately we hope our work will lead to much-needed therapies to promote remyelination in patients.